GSK ends Arzerra patent dispute with Genentech and nonprofit

03/27/2012 | Reuters

Genmab said marketing partner GlaxoSmithKline resolved a patent dispute with Roche Holding unit Genentech and California nonprofit City of Hope concerning Genmab's blood cancer drug Arzerra, or ofatumumab.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA